Cara Haymaker

11.5k citations

130 papers · 2.5k indexed · h-index 27

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research

Papers in

Immunology 76
- Immunotherapy and Immune Responses 48
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 18
- Immune cells in cancer 9
Oncology 97
- Cancer Immunotherapy and Biomarkers 65
- CAR-T cell therapy research 51
- Pancreatic and Hepatic Oncology Research 10

Co-authors: Chantale Bernatchez Laszlo Radvanyi Marie-Andrée Forget Patrick Hwu Richard C. Wu Ignacio I. Wistuba Adi Diab Edwin R. Parra
Journals: Journal of Clinical Oncology (30 papers)Annals of Oncology (10 papers)The Journal of Immunology (9 papers)Journal for ImmunoTherapy of Cancer (8 papers)Cancer Immunology Research (5 papers)
Partner nations: United States Australia France

In The Last Decade

Cara Haymaker

120 papers receiving 2.5k citations

Peers

Countries citing papers authored by Cara Haymaker

Since Specialization

Citations

This map shows the geographic impact of Cara Haymaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara Haymaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara Haymaker more than expected).

Fields of papers citing papers by Cara Haymaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara Haymaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara Haymaker. The network helps show where Cara Haymaker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cara Haymaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cara Haymaker Line = papers co-authored together Cara Haymaker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal Journal of Clinical Oncology ·Herman Tandilimbong, Kristen K. Ciombor, Lianchun Xiao, Kwadwo Nketia Kumankuma Sarpong, Enrica Marmonti, Blasé N. Polite, Benjamin A. Weinberg, John C. Krauss, K Prejilda, Juán Sebastián Córdoba Bojacá, Olivia Aranha, Shen Xu, Huaiqiang Liu, NM Elsharnouby, Syed Mohammad Ali Kazmi, Christopher H. Lieu, Howard S. Höchster, Jennifer G. Whisenant, Cara Haymaker, Cathy Eng	2026	0
2	Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors Journal for ImmunoTherapy of Cancer ·Omar Pacha, Anisha B. Patel, Jonathan L. Curry, Cara Haymaker, Kees Benkendorfer, Dzifa Y. Duose, Ken Chen, Joud Hajjar, Aung Naing	2025	1
3	LSGI: interpretable spatial gradient analysis for spatial transcriptomics data Genome biology ·Qingnan Liang, Luisa M. Solis Soto, Cara Haymaker, Ken Chen	2025	0
4	Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma OncoImmunology ·Éric Brangier, Simin Kiany, Marie‐Andrée Forget, Roland L. Bassett, Michael A. Davies, Adi Diab, Jeffrey E. Gershenwald, Isabella C. Glitza, Jeffrey E. Lee, Anthony Lucci, Jennifer L. McQuade, Sapna P. Patel, Merrick I. Ross, Hussein A. Tawbi, Jennifer A. Wargo, Michael K. Wong, Chantale Bernatchez, Patrick Hwu, Cara Haymaker, Rodabe Navroze Amaria	2025	0
5	Metastasis-directed therapy (MDT) plus androgen deprivation therapy (ADT) for oligometastatic prostate cancer (omPC): Primary results of the EXTEND continuous ADT (cADT) basket plus combined analysis with the updated intermittent ADT (iADT) basket and immune correlatives. Journal of Clinical Oncology ·Alexander D. Sherry, Cara Haymaker, Bryan Fellman, Tharakeswara Bathala, Lucy Jarzabkowski, Suyu Liu, Stephen G. Chun, Amt für Vor und Frühgeschichte der Hansestadt Lübeck, 石井雅巳, Mustafa Al-Mashhadani, Matthew P. Deek, Ana M. Aparicio, Amado J. Zurita, Patrick G. Pilié, Bilal A. Siddiqui, Sumit K. Subudhi, Alexandre Reuben, Paul G. Corn, Phuoc T. Tran, Chad Tang	2025	1
6	Neoadjuvant immunotherapy for oropharynx cancer: Correlative studies and long-term outcomes from the CIAO trial. Journal of Clinical Oncology ·Daniel J. McGrail, Kaiyi Li, Kane, Faye M. Johnson, 道徳経済一体論研究会, Diana Bell, S.S. Masudi, Cara Haymaker, Adam S. Garden, Shiaw‐Yih Lin, J. Jack Lee, Maura L. Gillison, Neil D. Gross, Andrew G. Sikora, Renata Ferrarotto	2024	1
7	OBX-115, an interleukin 2 (IL2)-sparing engineered tumor-infiltrating lymphocyte (TIL) cell therapy, in patients (pts) with immune checkpoint inhibitor (ICI)-resistant unresectable or metastatic melanoma. Journal of Clinical Oncology ·Rodabe N. Amaria, Jennifer L. McQuade, Michael A. Davies, Isabella Claudia Glitza, Edwin Stanly Escobar-Pineda, Erik N. K. Cressman, 傅淳, Roland L. Bassett, Sapna P. Patel, Adi Diab, Hussein A. Tawbi, Michael K. Wong, Alexandra P. Ikeguchi, Cara Haymaker, Nathally Botoluzzi, Madan Jagasia, Giridharan Ramsingh, Prakash Prabhakar, Cassidy M. Spaeth, Parameswaran Hari	2024	17
8	Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications Frontiers in Immunology ·A Meinke, Renganayaki Pandurengan, Edwin R. Parra, Catharina Vendl, Cara Haymaker	2023	3
9	Identification of Colorectal Cancer Cell Stemness from Single-Cell RNA Sequencing Molecular Cancer Research ·Kangyu Lin, Saikat Chowdhury, Mohammad A. Zeineddine, M.-C. Seghaye, Nicholas J. Hornstein, Ramesh TR, Dipen M. Maru, Cara Haymaker, Jean‐Nicolas Vauthey, George J. Chang, A. MYERSON, David G. Menter, Scott Kopetz, John Paul Shen	2023	8
10	Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer Nature Communications ·Edwin R. Parra, Jiexin Zhang, Mei Jiang, Auriole Tamegnon, Renganayaki Pandurengan, Carmen Behrens, Luisa M. Solis, Cara Haymaker, John V. Heymach, César A. Moran, J. Jack Lee, Don L. Gibbons, Ignacio I. Wistuba	2023	22
11	Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial International Journal of Radiation OncologyBiologyPhysics ·Alexander D. Sherry, Cara Haymaker, Tharakeswara Bathala, Xian Lu, Lucy Jarzabkowski, Enrica Marmonti, 莫敖, Putri Natalia Hutabarat, Bryan Fellman, Luming ZHANG, 智恵沢田, Stephen G. Chun, Ana M. Aparicio, 吕俊, I. Djan, Daniel R. Gomez, Alexandre Reuben, Ignacio I. Wistuba, Paul G. Corn, Chad Tang	2023	1
12	Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer Cancer Discovery ·Aislyn Schalck, Donastas Sakellariou-Thompson, Marie‐Andrée Forget, Emi Sei, DOROTHY M. WILLIAMSON, Alexandre Reuben, Shanshan Bai, Min Hu, Tapsi Kumar, Mark W. Hurd, Matthew H. G. Katz, Ching‐Wei D. Tzeng, Shubham Pant, Milind Javle, Seon-Heum Park, Anirban Maitra, Cara Haymaker, Michael P. Kim, Nicholas E. Navin, Chantale Bernatchez	2022	44
13	CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling Journal for ImmunoTherapy of Cancer ·Samantha M. Fix, Marie‐Andrée Forget, Donastas Sakellariou-Thompson, Yunfei Wang, Kamal Sleem, S.S. Masudi, Cara Haymaker, Ana Lucía Dominguez, Rafet Başar, Ronald B. George, Sanjay Kumar, Larissa A. Meyer, Patrick Hwu, Chantale Bernatchez, Amir A. Jazaeri	2022	29
14	Pathological Response and Immune Biomarker Assessment in Non-Small-Cell Lung Carcinoma Receiving Neoadjuvant Immune Checkpoint Inhibitors Cancers ·Jan Oosthoek, Edwin R. Parra, Ignacio I. Wistuba, Cara Haymaker, Luisa M. Solis Soto	2022	7
15	Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors Clinical Cancer Research ·Apostolia M. Tsimberidou, Philip Beer, Carrie Cartwright, Cara Haymaker, Henry Hiep Vo, Simin Kiany, Alexander Cecil, FRANCIS J. GAVIN, Gor A. Gevorgian, 正晟杉原, L.J. Reha-Krantz, Meylisa Dwi Cahyanti, Elisabeth A. Bone, Graciela M. Nogueras‐González, David Vining, 嘉夫今野, Ignacio I. Wistuba	2021	46
16	Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies Clinical Cancer Research ·Jaewon J. Lee, Vincent Bernard, Alexander Semaan, Maria E. Monberg, Jonathan Huang, Bret M. Stephens, Daniel Lin, Kimal Rajapakshe, Brian Weston, Manoop S. Bhutani, Cara Haymaker, Chantale Bernatchez, Cullen M. Taniguchi, Anirban Maitra, Paola A. Guerrero	2021	68
17	Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells Cancer Immunology Research ·Junmei Wang, Thangjam Memota Devi, Tobias Boeck, Haiyan S. Li, Jungsun Park, 江浪唐, Cara Haymaker, Chantale Bernatchez, Dean A. Lee, Stephanie S. Watowich, Cassian Yee	2020	17
18	A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors Cancer Discovery ·Salah-Eddine Bentebibel, Michael E. Hurwitz, Chantale Bernatchez, Cara Haymaker, Courtney W. Hudgens, Harriet M. Kluger, Michael T. Tetzlaff, Mary Tagliaferri, Jonathan Zalevsky, Ute Hoch, Christie Fanton, Sandra Aung, Patrick Hwu, Brendan D. Curti, Nizar M. Tannir, Mario Sznol, Adi Diab	2019	169
19	Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter Clinical Cancer Research ·Krit Ritthipichai, Cara Haymaker, Gabriela Tomas Jeron ., Kseniya Klimenko, Xiaohui Yi, Minying Zhang, Sergei V. Redkozubov, Luis M. Vence, Jason Roszik, Yared Hailemichael, Willem W. Overwijk, Navin Varadarajan, Roza Nurieva, Laszlo Radvanyi, Patrick Hwu, Chantale Bernatchez	2017	54
20	4-1BB–Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells Cancer Immunology Research ·Michiko Harao, Marie-Andrée Forget, Jason Roszik, Hui Gao, Gildy V. Babiera, Savitri Krishnamurthy, Jessica Chacon, Shumin Li, Elizabeth A. Mittendorf, Sarah M. DeSnyder, von C. Mussler, Chantale Bernatchez, Naoto T. Ueno, Laszlo Radvanyi, Luis M. Vence, Cara Haymaker, James M. Reuben	2017	49

About Cara Haymaker

Cara Haymaker is a scholar working on Immunology, Oncology, Biotechnology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 130 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (65 papers), CAR-T cell therapy research (51 papers), Immunotherapy and Immune Responses (48 papers), Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (18 papers), Pancreatic and Hepatic Oncology Research (10 papers), Cancer Research and Treatments (9 papers) and Immune cells in cancer (9 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.6k citations), Cancer Research (246 citations), Pulmonary and Respiratory Medicine (313 citations) and Molecular Biology (605 citations). Cara Haymaker has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Chantale Bernatchez, Laszlo Radvanyi, Marie-Andrée Forget, Patrick Hwu, Richard C. Wu, Patrick Hwu, Ignacio I. Wistuba, Adi Diab, Edwin R. Parra and Jessica Chacon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Immunology, Journal for ImmunoTherapy of Cancer and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact